Former TODAY anchor Katie Couric joins Studio 1A, along with her Stand Up to Cancer colleague Dr. Charles Fuchs, to raise awareness about colon cancer, the disease Couric’s husband died from in 1998.
Despite decades of research, brain tumours remain among the deadliest of all forms of cancer. The ability of these tumours to resist almost all conventional and novel treatments relates, in part, to the unique cell-intrinsic and microenvironmental properties of neural tissues.
Vice Chair of the SU2C Scientific Advisory Committee, Lee J. Helman, MD comments on the $500MM for pediatric cancer recommended in the State of the Union speech could bring additional researchers into the field of pediatric cancer research.
Stand Up To Cancer (SU2C) has put together an $8 million “dream team” of expert scientists who will focus on discovering new treatments for T-cell lymphoma based on CAR T-cell immunotherapy.
The pair of clinical investigators will join in a bicoastal collaboration to use radiation and immunotherapy pre-operatively to help the body create its own vaccine to fight breast cancer.
The endowment will be used to support SU2C’s annual operating activities and fund its life-saving cancer research.
SU2C “Convergence” and “Cancer Interception” researchers Regina Barzilay, PhD and Lecia Sequist. MD, PhD discuss AI to find cancers earlier, even before abnormal cells turn into the disease.
Pancreatic Cancer Collective scientists, Dr. Carl June and Dr. David Tuveson suggest CAR T cell therapies can require as little as three days of culture time at SITC 2018.
Receiving the Nobel prize is an extraordinary lifetime achievement, but the impact of Dr. Jim Allison’s research can be life-changing for the patients who benefit, as shared in this personal account.
